Genmab A (GMAB) EBT Margin (2018 - 2026)

Genmab A's (GMAB) quarterly EBT Margin came in at 11.83% in Q1 2026, down 4596.0% YoY from 0.26% in Q1 2025, and down 127.41% on a QoQ basis from 43.16% in Q3 2025.

Genmab A (GMAB) EBT Margin (2018 - 2026) Analysis & Trends

Genmab A (GMAB) has 5 years of EBT Margin data on file, last reported at 11.83% in Q1 2026.

  • Quarterly EBT Margin fell 4596.0% year-over-year to 11.83% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33.05% (down 489.0% YoY) and the FY2025 annual result came in at 32.37%, down 1012.0% from the prior year.
  • EBT Margin eased to 11.83% in Q1 2026, from 43.16% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 43.16% in Q3 2025 to a low of 11.83% in Q1 2026.
  • A 3-year average of 32.07% and a median of 40.23% in 2024 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2025 — EBT Margin soared 636 bps — and 2026, when it slumped 4596 bps.
  • Tracing GMAB's EBT Margin over 3 years: stood at 36.81% in 2024, then climbed by 17 bps to 43.16% in 2025, then tumbled by 127 bps to 11.83% in 2026.
  • The last three EBT Margin figures came in at 11.83% (Q1 2026), 43.16% (Q3 2025), and 40.67% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Genmab A 2.05 Bn 548.77 Mn 1.07 Bn 25.54%

Historic Data

Download Data
DateValue
Jun 30, 2026 25.54%
Mar 31, 2026 -11.83%
Sep 30, 2025 43.16%
Jun 30, 2025 40.67%
Mar 31, 2025 34.13%
Sep 30, 2024 36.81%
Jun 30, 2024 40.23%
Mar 31, 2024 41.29%
Dec 31, 2019 0.00%
Sep 30, 2019 67,248,452,652,513.27%
Dec 31, 2018 38.52%